We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+8.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.6B
AUM Growth
+$769M
(+16%)
Cap. Flow
+$469M
Cap. Flow
% of AUM
8.38%
Top 10 Holdings %
Top 10 Hldgs %
13.16%
Holding
1,266
New
125
Increased
352
Reduced
429
Closed
264
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$58.9M |
| 2 |
EOG Resources
EOG
|
+$37.7M |
| 3 |
Yum! Brands
YUM
|
+$29.2M |
| 4 |
Agilent Technologies
A
|
+$25.5M |
| 5 |
Occidental Petroleum
OXY
|
+$24.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gen Digital
GEN
|
+$27.1M |
| 2 |
Intercontinental Exchange
ICE
|
+$26M |
| 3 |
Global Payments
GPN
|
+$24.2M |
| 4 |
Cadence Design Systems
CDNS
|
+$22.8M |
| 5 |
Apple
AAPL
|
+$22.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.55% |
| 2 | Financials | 15.15% |
| 3 | Healthcare | 14.96% |
| 4 | Consumer Discretionary | 10.52% |
| 5 | Industrials | 10.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRSH
276
Marsh
MRSH
$86.3B
| $4.78M | 0.09% |
+71,010
| New | +$4.76M |
|
277
Dolby
DLB
$4.72B
| $4.75M | 0.08% |
87,470
+15,840
| +22% | +$793K |
|
278
CACI
CACI
$10.8B
| $4.67M | 0.08% |
46,260
+3,920
| +9% | +$378K |
|
279
Chubb
CB
$140B
| $4.62M | 0.08% |
+36,734
| New | +$4.66M |
|
280
Domino's
DPZ
$11B
| $4.59M | 0.08% |
30,200
| – | – |
|
281
Boston Properties
BXP
$11B
| $4.57M | 0.08% |
33,552
+334
| +1% | +$46.4K |
|
|
KND
282
DELISTED
Kindred Healthcare
KND
| $4.57M | 0.08% |
447,209
+130,622
| +41% | +$1.45M |
|
283
Shenandoah Telecom
SHEN
$632M
| $4.42M | 0.08% |
162,640
+150,640
| +1,255% | +$4.84M |
|
284
Idexx Laboratories
IDXX
$42.9B
| $4.37M | 0.08% |
38,740
-2,360
| -6% | -$249K |
|
285
Landstar System
LSTR
$6.8B
| $4.36M | 0.08% |
64,095
+19,724
| +44% | +$1.36M |
|
|
OCLR
286
DELISTED
Oclaro Inc.
OCLR
| $4.35M | 0.08% |
508,762
-144,625
| -22% | -$1.01M |
|
287
Thor Industries
THO
$3.99B
| $4.33M | 0.08% |
51,100
+6,430
| +14% | +$500K |
|
288
HF Sinclair
DINO
$15.9B
| $4.31M | 0.08% |
175,850
+20,360
| +13% | +$512K |
|
289
MarketAxess Holdings
MKTX
$4.15B
| $4.26M | 0.08% |
25,740
-2,480
| -9% | -$403K |
|
290
Amkor Technology
AMKR
$16.1B
| $4.25M | 0.08% |
436,838
+402,838
| +1,185% | +$3.23M |
|
|
ACH
291
Accendra Health
ACH
$240M
| $4.21M | 0.08% |
121,310
+8,340
| +7% | +$292K |
|
292
Knowles
KN
$3.22B
| $4.21M | 0.08% |
299,600
-143,750
| -32% | -$2.04M |
|
293
Synaptics
SYNA
$4.41B
| $4.18M | 0.07% |
+71,442
| New | +$3.93M |
|
|
BNY
294
Bank of New York Mellon
BNY
$108B
| $4.16M | 0.07% |
104,280
+12,800
| +14% | +$511K |
|
295
Agios Pharmaceuticals
AGIO
$2.16B
| $4.15M | 0.07% |
78,537
+45,347
| +137% | +$1.97M |
|
|
KYNB
296
Kyntra Bio
KYNB
$28.5M
| $4.11M | 0.07% |
7,942
+1,232
| +18% | +$580K |
|
297
Fortinet
FTNT
$112B
| $4.05M | 0.07% |
548,650
+396,100
| +260% | +$2.77M |
|
|
DF
298
DELISTED
Dean Foods Company
DF
| $4.02M | 0.07% |
245,306
-22,200
| -8% | -$388K |
|
299
Benchmark Electronics
BHE
$2.91B
| $4.02M | 0.07% |
161,020
-13,093
| -8% | -$310K |
|
300
Hyster-Yale Materials Handling
HY
$593M
| $3.98M | 0.07% |
66,278
-4,300
| -6% | -$244K |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q3 2016 Portfolio in Review
As of Q3 2016, Jacobs Levy Equity Management held 1,266 positions worth $5.6B, up 16% from $4.83B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management deployed $469M of net new capital in Q3 2016, opening 125 new positions and adding to 352 existing holdings. Its largest new stake was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Intercontinental Exchange, an estimated $26M trimmed.
- Jacobs Levy Equity Management's largest Q3 2016 buy was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
- Jacobs Levy Equity Management added most to Agilent Technologies in Q3 2016, an estimated $25.5M increase.
- Jacobs Levy Equity Management's biggest Q3 2016 reduction was Intercontinental Exchange, cutting an estimated $26M.
- Jacobs Levy Equity Management fully exited Gen Digital in Q3 2016, selling an estimated $27.1M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $5.6B portfolio in Q3 2016.
- Jacobs Levy Equity Management opened 125 new positions and closed 264 in Q3 2016.
- Jacobs Levy Equity Management's portfolio value rose 16% quarter-over-quarter to $5.6B.
Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.